Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
10 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250710548478/en/Zai-Lab-to-Announce-Second-Quarter-2025-Financial-Results-and-Recent-Corporate-Updates-on-August-7-2025
01 Jul 2025
// BIOSPACE
https://www.biospace.com/drug-development/amgens-antibody-improves-overall-survival-in-phase-iii-gastric-cancer-test
30 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250630980449/en/Zai-Lab-Announces-Positive-Topline-Phase-3-Results-for-Bemarituzumab-in-Fibroblast-Growth-Factor-Receptor-2b-FGFR2b-Positive-First-Line-Gastric-Cancer
13 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250613588431/en/Zai-Lab-Presents-New-Preclinical-Data-for-ZL-1503-an-IL-13IL-31R-Bispecific-Antibody-for-the-Treatment-of-Atopic-Dermatitis-at-EAACI-Congress-2025
02 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250602617824/en/Zai-Lab-Presents-Positive-Phase-1-Data-for-ZL-1310-a-DLL3-Targeted-ADC-Demonstrating-Robust-Anti-Tumor-Activity-and-Safety-in-Patients-with-Extensive-Stage-Small-Cell-Lung-Cancer-at-2025-ASCO-Annual-Meeting
31 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531848054/en/Zai-Lab-and-Novocure-Announce-Results-From-the-Phase-3-PANOVA-3-Trial-of-Tumor-Treating-Fields-TTFields-Therapy-for-Pancreatic-Cancer-to-be-Presented-at-2025-ASCO-Annual-Meeting
ABOUT THIS PAGE